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OBJECTIVES This study sought to evaluate whether objective assessment of the myocardial functional
reserve, using strain rate imaging (SRI), allows accurate detection of viable myocardium.
BACKGROUND Strain rate imaging is a new echocardiographic modality that allows quantitative assessment
of segmental myocardial contractility.
METHODS In 37 patients (age 58  9 years) with ischemic left ventricular dysfunction, myocardial
viability was assessed using low-dose (10 g/kg body weight per min) two-dimensional
dobutamine stress echocardiography (DSE), tissue Doppler imaging, SRI and 18F-
fluorodeoxyglucose (18FDG) positron emission tomography (PET). The peak systolic tissue
Doppler velocity and peak systolic myocardial strain rate were determined at baseline and
during low-dose dobutamine stress from the apical views.
RESULTS A total of 192 segments with dyssynergy at rest were classified by 18FDG PET as viable in
94 and nonviable in 98. An increase of peak systolic strain rate from rest to dobutamine
stimulation by more than 0.23 1/s allowed accurate discrimination of viable from nonviable
myocardium, as determined by 18FDG PET with a sensitivity of 83% and a specificity of 84%.
Receiver operating characteristic (ROC) curve analysis showed an area under the curve for
prediction of nonviable myocardium, as determined by 18FDG PET using SRI, of 0.89 (95%
confidence interval [CI] 0.88 to 0.90), whereas the area under the ROC curve using tissue
Doppler imaging was 0.63 (95% CI 0.61 to 0.65).
CONCLUSIONS The increase in the peak systolic strain rate during low-dose dobutamine stimulation allows
accurate discrimination between different myocardial viability states. Strain rate imaging is
superior to two-dimensional DSE and tissue Doppler imaging for the assessment of
myocardial viability. (J Am Coll Cardiol 2002;39:443–9) © 2002 by the American College
of Cardiology
The identification of dysfunctional but viable myocardium
in patients with depressed left ventricular (LV) function has
important therapeutic and prognostic implications (1). Al-
though dobutamine stress echocardiography (DSE) has
been demonstrated to be a reliable technique for identifica-
tion of myocardial viability, 18F-fluorodeoxyglucose
(18FDG) positron emission tomography (PET) remains the
reference technique for detection of viable myocardium
(2,3). An advantage of PET is the possibility of a quanti-
tative analysis. In contrast, DSE relies on a subjective
interpretation of wall motion (4,5). Tissue Doppler imaging
(TDI) has been suggested for quantitative analysis of
regional myocardial function (6,7). It allows the assessment
of local tissue velocities (point velocities). The point velocity
of a specific LV region, however, does not differentiate
between active contraction and passive drawing motion
related to translation and rotation of the whole heart or
contraction of adjacent segments. Strain rate imaging (SRI)
is a new technique derived from TDI, which allows the
determination of velocity gradients between two points in
space. The resulting contraction variable is independent of
passive tethering effects from other regions and therefore
appears promising for quantification of regional myocardial
function (8,9). Although the technique has been validated
in animal models, there is only little experience in clinical
settings (10–12). This study evaluated the use of SRI, in
combination with LV stimulation, using dobutamine for the
identification of viable myocardium determined by 18FDG
PET in patients with significant LV dysfunction.
METHODS
Study group. This study was approved by the local Ethical
Committee, and all subjects gave written, informed consent.
A total of 37 patients (58  9 years; 29 men) with reduced
LV function (ejection fraction 43.5  9.9%) due to a
previous myocardial infarction who underwent DSE, TDI,
SRI and 18FDG PET for the evaluation of viable myocar-
dium were included. Coronary angiography and cineven-
triculography were performed in all patients.
Echocardiography. Echocardiograms were obtained with a
Vivid Five System (GE Vingmed Sound AS, Horton,
Norway). Apical long-axis, two- and four-chamber views
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were acquired. The LV was divided according to the
16-segment model of the American Society of Echocardi-
ography (13).
Dobutamine echocardiography. Dobutamine infusion
was started at 5 g/kg body weight per min for 5 min,
followed by 10 g/kg per min for another 5 min. Images
were acquired continuously on tape and stored digitally at
the end of every dose step. The aim was to observe the
monophasic response. Each LV segment was scored at rest
and during dobutamine stimulation as normokinetic, mildly
hypokinetic, severely hypokinetic, akinetic or dyskinetic.
Depending on the contractility at rest and at low-dose
dobutamine, segments were described as 1) normal: normal
contractility or mild hypokinesia at rest and with dobut-
amine; 2) viable: severely hypokinetic, akinetic or dyskinetic
segments at rest, with improvement by at least one grade
with dobutamine administration; and 3) nonviable: severe
wall motion abnormality at rest, without improvement with
dobutamine.
Tissue Doppler imaging. Color tissue Doppler recordings
were obtained at rest and during dobutamine stress using
the same apical transducer positions. Digital data were
transferred for off-line analysis, applying the software incor-
porated in the Vivid Five System (GE Vingmed). This
allowed determination of the tissue Doppler velocity of a
chosen sample volume for each instant during one cardiac
cycle. The peak systolic tissue velocity was determined as the
maximal positive velocity within 350 ms after the QRS
complex. It was evaluated for each segment of the 16-
segment model at rest and during dobutamine stimulation,
placing the sample volume in the basal part of each segment
halfway between the endocardium and epicardium. Auto-
correction of sample volume location during systolic con-
traction accounted for the inward motion of the ventricular
wall to keep the sample volume halfway between the
endocardium and epicardium. Three consecutive beats were
analyzed.
Strain rate imaging. This type of imaging is an extension
of TDI, which determines the velocity gradient between
two points along the ultrasound beam. The strain rate (SR)
is equivalent to the spatial gradient of velocity. It is
characterized by the equation: SR  (v[r]  v[r  r])/r,
as described previously (9). An offset of r 1 cm was used
in all studies. Strain rate imaging was performed from the
apical long-axis, two- and four-chamber views. This al-
lowed the determination of a baso-apical velocity gradient
within each segment. During SRI, the image sector was
kept as narrow as possible to achieve the highest possible
frame rates. For this purpose, only one wall (septal, lateral,
posterior, anterior, inferior and anteroseptal) was imaged at
a time. This allowed achievement of frame rates 140/min
with real-time display of SR color images and also mainte-
nance of the angle between the Doppler beam and the
longitudinal shortening direction of the wall at 30°.
Digital data were transferred to customized, dedicated
research software (GE Vingmed). This made it possible to
determine the SR at any instant during one cardiac cycle.
The peak systolic SR was determined as the maximal
negative SR within 350 ms after the QRS complex. It was
determined for each segment at rest and with dobutamine.
Positioning of the sample volume and autocorrection of
sample volume location were done as described for TDI.
The SR data were averaged from three consecutive beats.
Cardiac cycles with disturbance of the rhythm were ex-
cluded.
Positron emission tomography. The PET protocol has
been described in detail (14). Technetium-99m (99mTc)-
tetrofosmin was used as marker of myocardial perfusion and
18FDG as a marker of myocardial metabolism. Myocardial
perfusion imaging was performed 60 min after injection of
10 mCi of 99mTc-tetrofosmin. Acquisition of PET images
was performed at the same day of the DSE examination.
Static emission scans were acquired 45 to 60 min after
injection of 5 mCi of 18FDG. Reoriented tetrofosmin and
18FDG data were simultaneously quantified by an automatic
count-based algorithm using the 16 segments of the echo-
cardiographic model. Tetrofosmin and 18FDG uptake in
each segment was expressed as a percentage of the region
with the maximal tetrofosmin uptake. Depending on 99mTc
tetrofosmin and 18FDG tracer uptake, myocardial segments
were classified into three groups: 1) normal segments,
defined by a tetrofosmin uptake 70%; 2) mismatch (via-
ble) segments, defined by a tetrofosmin uptake 70% and a
better preserved 18FDG uptake (18FDG  tetrofosmin
uptake 20%); and 3) intermediate and match segments
(nonviable), defined by a concordant reduction of both
tracers to 70%.
Coronary angiography and cineventriculography. The
severity of coronary stenosis was determined quantitatively
(QuantCor, CASS II, Siemens, Erlangen, Germany).
Monoplane planimetry of cineventriculograms was per-
formed to determine the LV ejection fraction.
Statistics. Data are expressed as the mean value  SD. To
compare segmental TDI data with SR data at rest and
during dobutamine, relative to the results of 18FDG PET,
we used a summary statistic. This required a calculation of
mean values for viable and nonviable segments, respectively,
per patient. Then, the paired Student t test, at the very
conservative Bonferroni-adjusted individual significance
Abbreviations and Acronyms
CI  confidence interval
DSE  dobutamine stress echocardiography
18FDG  18F-fluorodeoxyglucose
LV  left ventricle or ventricular
PET  positron emission tomography
ROC  receiver operating characteristic
SR  strain rate
SRI  strain rate imaging
99mTc  technetium-99m
TDI  tissue Doppler imaging
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level (0.05/15; number of comparisons  15), was per-
formed to compare viable with nonviable segments in 37
patients. The global significance level was set at 0.05.
Recently described nonparametric analysis of overall sensi-
tivities and specificities, as well as areas under the receiver
operating characteristic (ROC) curves, was applied (15).
Analysis of ROC curves was used to assess the optimal
cut-off point of the increase in systolic peak SR and of the
increase in systolic peak tissue velocity for the detection of
myocardial viability.
RESULTS
Significant coronary artery stenosis (50% diameter steno-
sis) was documented in each patient. Visual assessment of
wall motion was possible in 556 (94%) of the 592 segments.
A total of 344 segments (62%) demonstrated normal func-
tion, and 212 segments were dyssynergic at rest.
18FDG PET. Of the 212 dyssynergic segments, 69 seg-
ments (32%) were found to have normal perfusion and
metabolism and 35 segments (17%) to be viable with
depressed perfusion. The combined 104 segments were
subsequently compared with 108 segments (51%) with a
match or intermediate finding, which were defined as
nonviable.
Two-dimensional DSE. A total of 119 (56%) of 212
segments showing severe dyssynergy at rest did not show
improvement in wall motion with dobutamine stimulation
and were considered nonviable. There were 93 segments
(44%) that were considered viable.
Tissue Doppler imaging. Analysis of TDI samplings was
feasible in 92% of all segments, including 192 of the 212
segments defined as dyssynergic by two-dimensional echo-
cardiography. These 192 dyssynergic segments were divided
on the basis of the 18FDG PET results into 94 segments
showing viability and 98 segments showing nonviability.
Peak systolic tissue Doppler velocities at rest and during
dobutamine stimulation, as well as the increase from rest to
dobutamine stimulation for the different viability states, as
determined by 18FDG PET, are given in Table 1. At rest,
viable myocardium had a peak systolic tissue Doppler
velocity similar to that of nonviable myocardium. During
low-dose dobutamine stimulation, the peak systolic tissue
Doppler velocity increased significantly for both viable
myocardium and nonviable myocardium. The increase in
the peak systolic tissue Doppler velocity was not signifi-
cantly different between viable and nonviable myocardium.
Systolic SR sampling. Analysis of SR samplings was
possible in 542 segments (92%). Strain rate analysis was
possible in the same 192 segments with dyssynergy at rest,
as in TDI. Peak systolic SR data at rest and during
dobutamine stimulation for the different viability states, as
determined by 18FDG PET, are given in Table 2. Peak
systolic SR was similar at rest for both viable and nonviable
myocardium. During dobutamine stimulation, the peak
systolic SR increased significantly for viable myocardium,
whereas it remained unchanged for nonviable myocardium
(Table 2). Figures 1 and 2 show SR images and the analysis
of SR curves of a dyssynergic segment found to be viable by
18FDG PET.
In addition, the relationship between SR data and PET
results for all LV segments, including segments with normal
function, was analyzed. Peak systolic SR at rest was 0.85 
0.39 l/s for myocardium defined as normal or viable by
PET, and 0.64  0.32 l/s for myocardium defined as
Table 1. Peak Tissue Doppler Velocity at Rest and During Dobutamine Stimulation Related to
Results of 18F-Fluorodeoxyglucose Positron Emission Tomography for 192 Dyssynergic
Segments at Rest
Normal or Viable
(n  94 Segments
in 37 Patients)
Nonviable
(n  98 Segments
in 37 Patients) p Value
Peak systolic TDV at rest (cm/s) 1.99  1.08 2.00  1.18 0.7984
Peak systolic TDV with dobutamine (cm/s) 3.50  1.75* 3.08  1.43† 0.4161
Increase in peak systolic TDV (cm/s) 1.51  1.36 1.08  0.86 0.3095
*p  0.0001 vs. peak systolic TDV at rest (normal or viable); †p  0.0001 vs. peak systolic TDV at rest (nonviable).
Bonferroni-corrected individual significance levels are 0.05/15. Data are expressed as the mean value  SD.
TDV  tissue Doppler velocity determined by tissue Doppler imaging.
Table 2. Peak Systolic SR Data at Rest and During Dobutamine Stimulation Related to Results
of 18F-Fluorodeoxyglucose Positron Emission Tomography for 192 Dyssynergic Segments
at Rest
Normal or Viable
(n  94 Segments
in 37 Patients)
Nonviable
(n  98 Segments
in 37 Patients) p Value
Peak systolic SR at rest (l/s) 0.61  0.36 0.66  0.42 0.5875
Peak systolic SR with dobutamine (l/s) 1.22  0.43* 0.60  0.32†  0.0001
Increase in peak systolic SR (l/s) 0.61  0.36 0.07  0.35  0.0001
*p  0.0001 vs. peak systolic SR at rest (normal or viable); †p  0.3216 vs. peak systolic SR at rest (nonviable).
Bonferroni-corrected individual significance levels are 0.05/15. Data are expressed as the mean value  SD.
SR  strain rate.
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nonviable by 18FDG PET (p  0.001). Repeat analysis of
peak systolic SRI data was performed for 30 segments to
evaluate the reproducibility of SR data. There was a mean
difference of 0.05  0.03 l/s between the first and second
analysis.
Comparison of echocardiographic techniques for detec-
tion of viability. There was agreement between 18FDG
PET and two-dimensional DSE in the assessment of
viability in 66% of segments. This corresponded to a
sensitivity and specificity of two-dimensional DSE in the
detection of viability, as determined by 18FDG PET, of
75% and 63%, respectively. For changes in peak systolic
tissue velocities and changes in peak systolic SR, ROC curve
analysis was used to determine the cut-off value with the
highest sensitivity and specificity for the detection of via-
bility using 18FDG PET as reference. Tissue Doppler
imaging agreed in 66% and SRI in 83% of segments with
assessment of segmental viability by 18FDG PET. An
increase in peak systolic tissue velocity 1.05 cm/s had a
sensitivity of 69% and a specificity of 64% to predict
nonviability, as determined by 18FDG PET. The ROC
analysis showed an area under the curve of 0.63 (95%
confidence interval [CI] 0.61 to 0.65) for the prediction of
nonviable myocardium. An increase in SR below0.23 (l/s)
had a sensitivity of 83% and a specificity of 84% to predict
nonviability determined by 18FDG PET (Fig. 3). The ROC
analysis showed an area under the curve of 0.89 (95% CI
0.88 to 0.90) for the prediction of nonviable myocardium.
The difference between the ROC areas of SR and TDI was
Figure 2. Strain rate tracings at rest (solid line) and during dobutamine
stimulation (dotted line) for one cardiac cycle of a hypokinetic segment at
rest, shown to be viable by 18FDG PET. There is an increase in the peak
systolic strain rate from 1.1 1/s at rest to 2.0 l/s during dobutamine
stimulation.
Figure 1. Strain rate imaging of the septal wall at rest (upper) and during dobutamine stimulation (lower). The color changes from green to yellow for the
mid-anterior segment, indicating an increase of contractility. This segment has been shown to be viable by 18F-fluorodeoxyglucose positron emission
tomography.
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0.26 (95% CI 0.25 to 0.27). Table 3 shows that SR analysis
compared favorably with two-dimensional DSE and TDI
for the detection of viability.
DISCUSSION
This study demonstrated that: 1) SRI can be used for
assessment of myocardial function in a routine clinical
setting; 2) SRI, in combination with dobutamine stimula-
tion, is an accurate means to determine myocardial viability
determined by 18FDG PET; and 3) SRI compares favorably
with two-dimensional echocardiography and TDI in the
determination of myocardial viability determined by 18FDG
PET.
Myocardial viability. Two-dimensional DSE has been
used as a widely available and cheap method for assessment
of myocardial viability (2,3). However, the method is
limited by the subjective evaluation process (4,5). Assess-
ment of myocardial contractility in segments adjacent to
infarct-related areas is difficult. Endocardial excursion of a
segment may be due to active contraction or passive drawing
motion from adjacent segments. Assessment of wall thick-
ening may be challenging, as the epicardial visibility is often
low.
Tissue Doppler imaging. This imaging method has been
suggested for quantification of ventricular contractility and
objective assessment of stress echocardiograms (6,7,16,17).
However, TDI has several limitations. The velocity deter-
mined by TDI does not differentiate between active con-
traction and passive following of tissue. Thus, rotation and
translation movements of the whole heart, as well as active
contraction of segments adjacent to the analyzed segment,
may affect the determined velocity. The point velocity
measured by TDI may therefore incorrectly reflect the
contractility of the analyzed segment. Analysis of tissue
velocities by TDI from apical views is hampered by the fact
that the obtained velocities represent a cumulative velocity
of all segments apical to the analyzed segment. This results
in an increase of tissue velocities from the apex to base (6).
Furthermore, the impact of segments located apical to the
analyzed segment inhibits the ability to accurately determine
whether contractility is depressed at the level of the analyzed
segment. Several solutions have been suggested to circum-
vent these difficulties. Nishino et al. (18) applied M-mode
TDI, in combination with dobutamine stimulation, in the
post-myocardial infarction setting and reported a high
sensitivity for the prediction of reversible dysfunction. They
Figure 3. Plot of increase in strain rate during dobutamine stimulation determined by strain rate imaging and increase in tissue velocities during dobutamine
stimulation determined by tissue Doppler imaging for myocardial segments defined as normal or viable and for those defined as nonviable by
18F-fluorodeoxyglucose positron emission tomography.
Table 3. Diagnostic Accuracy of Two-Dimensional
Dobutamine Stress Echocardiography, TDI and SRI for
Detection of Viability Determined by 18F-Flurodeoxyglucose
Positron Emission Tomography
Sensitivity (%) Specificity (%)
Two-dimensional 75 (72–78) 63 (61–66)
TDI 69 (67–72) 64 (62–68)
SRI 83 (81–85) 84 (81–87)
SRI  strain rate imaging; TDI  tissue Doppler imaging.
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determined a velocity gradient between the endocardium
and epicardium both at rest and during dobutamine stress to
evaluate the functional reserve. Evaluation of TDI for only
the basal segment in the apical views has been described
(19). This resulted in the assessment of viability for a whole
ventricular wall from the apex to base. Although this
approach circumvents the difficulties of the segmental anal-
ysis related to the baso-apical tethering, it results in a loss of
spatial information on the exact pattern of viability distri-
bution.
Strain rate imaging. This new imaging method was de-
rived from color tissue Doppler imaging, which has recently
been implemented as a real-time modality (8,9). Strain and
SR can be determined by an algorithm that calculates spatial
differences in tissue velocities between neighboring myocar-
dial regions. Strain is the degree of lengthening or compres-
sion between two adjacent points in space. Strain rate equals
the rate of regional myocardial deformation. Thus, it is
equivalent to the velocity gradient between two points with
a small offset (8). The advantage of SR is that it is not
affected by global cardiac displacement and the tethering
effects of adjacent segments. Urheim et al. (9) demonstrated
in an animal model that systolic strain determined by
Doppler imaging correlates closely with strain determined
by sonomicrometry. In contrast, the relationship between
Doppler velocities and regional myocardial function was
much looser. Myocardial Doppler velocities of basal non-
ischemic myocardial segments were found to be reduced in
cases of apical ischemia, although regional strain was un-
changed. This was explained by the tethering effects. There
are limited data on the assessment of strain and SR by
Doppler echocardiography in clinical practice. Edvardsen et
al. (11) demonstrated in 17 patients that strain analysis is a
more accurate marker than TDI for detecting systolic
regional myocardial dysfunction induced by coronary occlu-
sion. Go¨tte et al. (12) demonstrated that strain analysis is
more accurate than planar wall thickening analysis in the
discrimination of dysfunctional from functional myocar-
dium after infarction. The present study related SR mea-
surements obtained at rest and during dobutamine stimu-
lation to myocardial viability determined by 18FDG PET.
The results of this study indicate that changes in SR during
dobutamine stimulation allow accurate assessment of myo-
cardial viability. Strain rate imaging was more accurate than
TDI for the assessment of myocardial viability. This should
be explained by the aforementioned difficulties of point
velocities determined by TDI to accurately reflect local
myocardial contractility and viability.
Study limitations. Only low-dose dobutamine stress was
applied in this study. Thus, assessment of the biphasic
response to evaluate myocardial viability was not possible.
However, we thought this was adequate, as previous studies
have demonstrated that the monophasic response at a low
dose identifies most viable segments or that peak dose
sampling does not add incremental value as compared with
low-dose sampling (19). The current technology of SRI is
characterized by considerable noise in the SR signal. We
believe that we could reduce the impact of this limitation by
averaging the results of three heartbeats. The mean differ-
ence between repeated measurements was much smaller
than the mean difference in SR between viable and nonvi-
able regions during dobutamine stimulation, indicating that
SR data can be used with sufficient confidence. However,
the noise in the SR signal increases with higher heart rates
and reduced image quality. The analysis of strain by Dopp-
ler echocardiography is very angle-dependent (8,9). Accu-
rate SR data can be expected only if the angle between the
ultrasonic beam and LV axis is very small (8). For this
reason, we performed SR analysis only for one myocardial
wall at a time and requested an angle between the ultrasonic
beam and LV axis of 20°. Because of the greater angle
between the ultrasonic beam and LV axis for apical seg-
ments, determination of SR for apical segments is likely to
be less accurate (8). 18FDG PET was used as the reference
standard to evaluate viability. However, although 18FDG
PET is an accurate marker of histologic viability, it has
limitations in the prediction of functional recovery after
revascularization (20). Future studies will need to show the
accuracy of SR results in comparison with two-dimensional
DSE and TDI for the prediction of functional improvement
after revascularization.
Conclusions. The increase of peak systolic myocardial SR
during low-dose dobutamine stimulation allows accurate
assessment of myocardial viability in patients with depressed
LV function after myocardial infarction. The method com-
pares favorably with TDI and two-dimensional DSE in the
evaluation of myocardial viability and is likely to be an
important step in the effort to objectively assess myocardial
contractility.
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